Cargando…
ITGB1BP1, a Novel Transcriptional Target of CD44-Downstream Signaling Promoting Cancer Cell Invasion
Breast cancer (BC) is the most common malignancy worldwide and has a poor prognosis, because it begins in the breast and disseminates to lymph nodes and distant organs. While invading, BC cells acquire aggressive characteristics from the tumor microenvironment through several mechanisms. Thus, under...
Autores principales: | Ahmad, Salma M S, Nazar, Hanan, Rahman, Md Mizanur, Rusyniak, Radoslaw Stefan, Ouhtit, Allal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225144/ https://www.ncbi.nlm.nih.gov/pubmed/37252376 http://dx.doi.org/10.2147/BCTT.S404565 |
Ejemplares similares
-
Novel CD44-downstream signaling pathways mediating breast tumor invasion
por: Ouhtit, Allal, et al.
Publicado: (2018) -
SOD2, a Potential Transcriptional Target Underpinning CD44-Promoted Breast Cancer Progression
por: Alateyah, Nouralhuda, et al.
Publicado: (2022) -
SIRT1, a novel transcriptional downstream target of CD44, linking its deacetylase activity to tumor cell invasion/metastasis
por: Ahmad, Salma M. S., et al.
Publicado: (2022) -
KYNU, a novel potential target that underpins CD44‐promoted breast tumour cell invasion
por: Al‐Mansoob, Maryam, et al.
Publicado: (2021) -
PCF11, a Novel CD44-Downstream Transcriptional Target, Linking Its 3’-End Polyadenylation Function to Tumor Cell Metastasis
por: Al-Mansoob, Maryam, et al.
Publicado: (2022)